The Wall Street Journal (online registration required): A Food and Drug Administration advisory committee voted Tuesday that there isn't enough evidence to say the anti-inflammatory painkiller naproxen is safer than other pain drugs when it comes to heart health.
The committee vote was 16-9 that naproxen, sold as Aleve by Bayer AG, can't be convincingly proven to have greater cardiac safety than ibuprofen, Celebrex and other nonsteroidal anti-inflammatory drugs. Ibuprofen is sold under...
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now